MARKET

ELOX

ELOX

Eloxx Pharmaceut
NASDAQ
10.69
+0.04
+0.38%
After Hours: 10.69 0 0.00% 19:30 11/20 EST
OPEN
10.90
PREV CLOSE
10.65
HIGH
10.94
LOW
9.90
VOLUME
14.98K
TURNOVER
--
52 WEEK HIGH
23.40
52 WEEK LOW
0.0011
MARKET CAP
43.69M
P/E (TTM)
-7.0347
1D
5D
1M
3M
1Y
5Y
1D
Eloxx Pharmaceuticals’ exaluren shows efficacy in Alport syndrome trial
TipRanks · 2d ago
Eloxx Pharmaceuticals Announces Publication of Phase 2a Exaluren Data in Nonsense Mutation Alport Syndrome in the Journal of Clinical Investigation
PR Newswire · 2d ago
Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), Henry Schein (HSIC) and Eloxx Pharmaceuticals (ELOX)
TipRanks · 3d ago
Eloxx Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
NASDAQ · 4d ago
Eloxx Pharmaceuticals GAAP EPS of -$0.49 beats by $0.09
Seeking Alpha · 4d ago
*Eloxx Pharmaceuticals: As of Sept 30, Had Cash and Cash Equivalents of $56.3M >ELOX
Dow Jones · 4d ago
*Eloxx Pharmaceuticals 3Q Loss/Shr 49c >ELOX
Dow Jones · 4d ago
*Eloxx Pharmaceuticals 3Q Loss $5.54M >ELOX
Dow Jones · 4d ago
More
About ELOX
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. The Company is also advancing ZKN-013 as an oral agent for the treatment of recessive dystrophic (RDEB)/ junctional epidermolysis bullosa (JEB) and familial adenomatous polyposis (FAP) patients with nonsense mutations. The Company also has preclinical programs focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, as well as rare ocular genetic disorders.

Webull offers Eloxx Pharmaceuticals Inc stock information, including NASDAQ: ELOX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELOX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELOX stock methods without spending real money on the virtual paper trading platform.